Acute Leukemias IV
暂无分享,去创建一个
[1] H. Kantarjian,et al. Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] L. Hertel,et al. Action of 2',2'-difluorodeoxycytidine on DNA synthesis. , 1991, Cancer research.
[3] W. Friedrich,et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. , 1991, Blood.
[4] E. Thiel,et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. , 1991, Annals of internal medicine.
[5] J. Armitage,et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. , 1991, The New England journal of medicine.
[6] J. Niland,et al. A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .
[7] Y. Kaneko,et al. Why does childhood acute lymphoblastic leukemia with hyperdiploidy show a favorable prognosis? , 1990, Cancer genetics and cytogenetics.
[8] Y Z Xu,et al. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine. , 1990, Molecular pharmacology.
[9] L. Secker-Walker. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. , 1990, Cancer genetics and cytogenetics.
[10] F. Behm,et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Jonathan J. Shuster,et al. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study , 1990 .
[12] J. Ritter,et al. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. AML-BFM Study Group. , 1990, Blood.
[13] V. Heinemann,et al. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine. , 1989, Biochemical pharmacology.
[14] C. Coltman,et al. Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] V. Heinemann,et al. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. , 1988, Cancer research.
[16] J. Gmür. [Allogeneic bone marrow transplantation]. , 1988, Therapeutische Umschau. Revue therapeutique.
[17] H. Gadner,et al. Die Behandlung der akuten lymphoblastischen Leukämie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81* , 1987 .
[18] R. Larson,et al. A clinical and pharmacokinetic study of mitoxantrone in acute nonlymphocytic leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] A. Look,et al. Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. , 1986, Blood.
[20] A. Bleyer,et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] H. Behrendt,et al. Phenotypic and karyotypic properties of hyperdiploid acute lymphoblastic leukaemia of childhood , 1985, British journal of haematology.
[22] R. Elashoff,et al. Treatment of Acute Myelogenous Leukemia: A Prospective Controlled Trial of Bone Marrow Transplantation Versus Consolidation Chemotherapy , 1985 .
[23] A. Look,et al. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia , 1984, Cell.
[24] H. Sather,et al. Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] K. Sullivan,et al. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse , 1983 .
[26] T. Necheles,et al. Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children. , 1983, The New England journal of medicine.
[27] H. Kizaki,et al. Role of GTP in CTP synthetase from Ehrlich ascites tumor cells. , 1982, Biochemical and biophysical research communications.
[28] N. Flournoy,et al. Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. , 1982, Annals of internal medicine.
[29] R. Storb,et al. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. , 1981, The New England journal of medicine.
[30] B. Barlogie,et al. Simultaneous determination of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate and 3-deazauridine 5'-triphosphate in human leukemia cells by high-performance liquid chromatography. , 1980, Journal of chromatography.
[31] D. Hedley,et al. THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA , 1980, The Lancet.
[32] R. Storb,et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. , 1979, Blood.
[33] P. Neiman,et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.
[34] F. Schabel,et al. THE MECHANISM OF ACTION OF 3‐DEAZAURIDINE IN TUMOR CELLS SENSITIVE AND RESISTANT TO ARABINOSYLCYTOSINE * , 1975, Annals of the New York Academy of Sciences.
[35] H. Weinfeld,et al. Purification and properties of mammalian liver cytidine triphosphate synthetase. , 1970, The Journal of biological chemistry.
[36] L. Jacobson,et al. EFFECT OF SPLEEN PROTECTION ON MORTALITY FOLLOWING X-IRRADIATION , 1949 .
[37] J. Wolff,et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. , 1948, The New England journal of medicine.
[38] I. Bernstein,et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] G. Henze,et al. Results and significance of six randomized trials in four consecutive ALL-BFM studies. , 1990, Haematology and blood transfusion.
[40] G. Gustafsson,et al. Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden. , 1989, Pediatric hematology and oncology.
[41] C. Pui,et al. Efficacy of high-dose methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications. , 1988, Blood.
[42] F. Appelbaum,et al. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. , 1988, Blood.
[43] E. Thomas,et al. Marrow transplantation for children with acute lymphoblastic leukemia in second remission. , 1987, Blood.
[44] A. Bleyer,et al. Analysis of prognostic factors in acute lymphoblastic leukemia. , 1986, Medical and pediatric oncology.
[45] W. Bleyer,et al. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. , 1985, Seminars in oncology.
[46] P. Neiman,et al. Cure of leukemia by marrow transplantation , 1977 .